There is much interest in the design and synthesis of chemical compounds that possess binding specificity comparable with that of bacterial repressors. These compounds could be used to affect selectively the activity of certain genes in bacterial and eukaryotic cells and might have important implications in pharmacology. In this paper we report several approaches to the design and synthesis of sequence-specific ligands.
No takes yet. Share an insight, caveat, or question.
Gursky et al. (1983) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: